Antimalarial drug effective alternative to canagliflozin in type 2 diabetes

Adults with type 2 diabetes inadequately controlled with a DPP-IV inhibitor plus metformin therapy experienced an improvement in glycemic control with the antimalarial drug hydroxychloroquine that was similar to the SGLT2 inhibitor canagliflozin, according to study data presented here.

Source: Antimalarial drug effective alternative to canagliflozin in type 2 diabetes